API2-MALT1 fusion and aneuploidy are common chromosomal abnormalities in MALT lymphoma. In studying their incidence and relationship in primary pulmonary MALT lymphomas, a translocation involving MALT1 and IGH was also identified. In all, 28 primary pulmonary MALT lymphomas were studied by fluorescence in situ hybridization using an API2-MALT1 probe and multiple centromeric probes, as well as IGH-BCL2, IGH-MALT1, and MALT1 breakapart probes in selected cases. Seven (25%) had API2-MALT1 fusion; all seven lacked aneuploidy except for two with trisomy 3 in a small clone. Three (11%) had IGH-MALT1 fusion; two also showed trisomy 3 and 12. A total of 11 (39%) had aneuploidy only, with trisomy 3 and 18 being the most common. Ectopic nuclear bcl-10 expression, which has been previously associated with API2-MALT1, was seen by immunohistochemistry in 86% of API2-MALT1 fusionpositive cases, one IGH-MALT1 fusion-positive case, two aneuploidy-only cases, and two normal cases. In primary pulmonary MALT lymphomas, cytogenetic abnormalities are common (75%) and heterogeneous, encompassing API2-MALT1 and IGH-MALT1, which are mutually exclusive, as well as aneuploidy, which may be present in the latter but is rare in the former. Ectopic nuclear bcl-10 expression is associated with API2-MALT1 but may also be seen in IGH-MALT1 fusionpositive, aneuploidy-only, and normal cases.
Introduction t(11;18)(q21;q21), which results in the production of a fusion protein composed of the apoptosis inhibitor API2 on chromosome 11q21 and the paracaspase MALT1 on chromosome 18q21, is thought to be the most common structural chromosomal abnormality in MALT lymphoma, occurring in 20-50% of cases. [1] [2] [3] [4] [5] [6] [7] [8] [9] This translocation is found exclusively in MALT lymphomas, and has not been identified in primary splenic or primary nodal marginal zone lymphomas. [1] [2] [3] When present, it is usually the sole cytogenetic abnormality and is primarily associated with low-grade disease, having been identified to date in only two cases of diffuse large B-cell lymphoma transformation of low-grade MALT lymphoma. 10, 11 Aneuploidy, particularly trisomy 3, 7, 12, and/or 18, is also common in MALT lymphoma but is rarely associated with t (11;18) , suggesting that MALT lymphomas with t(11;18) and those with aneuploidy develop along different pathogenetic pathways. 10 As most MALT lymphomas arise in the stomach, the majority of cytogenetic research has been performed on gastric MALT lymphomas. We chose to study primary pulmonary MALT lymphomas because although they have been relatively infrequently studied, the incidence of t(11;18) is thought to be highest in this site 10, 12 and aneuploidy has also been shown to be common in this site. 10 The initial aim of the study was to determine the incidence of and relationship between t(11;18) and aneuploidy in a series of primary pulmonary MALT lymphomas using fluorescence in situ hybridization (FISH) performed on nuclei isolated from paraffin-embedded tissue. In the course of this investigation, a translocation involving MALT1 and the immunoglobulin heavy chain gene (IGH) was also identified in three cases. While this manuscript was being prepared, two other reports identifying the same translocation in MALT lymphoma were published. 13, 14 However, to our knowledge this is the first report of IGH-MALT1 fusion in pulmonary MALT lymphomas.
Materials and methods

Patient samples
In all, 28 patients who were diagnosed with pure low-grade primary pulmonary MALT lymphoma at Mayo Clinic between 1981 and 1994 and who had suitable paraffin blocks available were identified. In all cases, rigorous clinical staging confirmed that the site of involvement was limited to one or both lungs. Each case was previously studied clinically, morphologically, and phenotypically by one of the authors (PJK), 15 and five cases were also previously studied by FISH in our laboratory. 10 All patients consented to research use of their tissue, and the study was approved by the Mayo Clinic Institutional Review Board. Each lymphoma met the morphologic and phenotypic criteria (by paraffin or frozen section immunohistochemistry or flow cytometry) of the World Health Organization Classification of Haematopoietic and Lymphoid Tissues, 16 and in each case sufficient paraffin-embedded material was available for isolation of nuclei for FISH.
Immunohistochemistry
Immunoperoxidase stains were applied to paraffin sections of all cases but one (due to insufficient tissue) according to previously published methods, 17 using antibodies directed against Bcl-10 (Zymed, South San Francisco, CA, USA).
FISH analysis
FISH was performed using a slight modification of a previously described method, 18 in that either 50-mm sections were cut or two tissue sample cores were collected using a 20-gauge 1.5-inch blunt needle from the paraffin block. The method used was otherwise identical to the previously described method. Briefly, to isolate nuclei, the samples were deparaffinized with xylene, rehydrated, manually disaggregated, enzymatically digested with a proteinase K solution, washed, resuspended, and placed on a charged glass slide. The slides were dried and sequentially treated with hot citric acid, 2 Â standard saline citrate, and pepsin. The slides were then dehydrated, probe was added to each slide, the DNA and probe were co-denatured and hybridized, and the slides were washed and counterstained. Cells were viewed with a fluorescent microscope equipped with appropriate filter sets.
FISH probes
Centromere-specific a-satellite (CEN) probes for chromosomes 3 and 12 were directly labeled with SpectrumOranget, and those for chromosomes 7 and 18 were directly labeled with SpectrumGreent (Vysis, Inc., Downers Grove, IL, USA). DNA probes for BCL2 (telomeric to the MALT1 gene at 18q21) and IGH (at 14q32) were directly labeled with SpectrumOranget and SpectrumGreent, respectively (Vysis, Inc., Downers Grove, IL, USA). DNA probes for API2 and MALT1 10 were directly labeled with SpectrumOranget and SpectrumGreent, respectively. DNA probes for MALT1 10 and IGH (consisting of the IGH component of the Vysis, Inc. BCL2-IGH probe set) were directly labeled with SpectrumOranget and SpectrumGreent, respectively. The MALT1 breakapart probe is composed of SpectrumOranget-and SpectrumGreent-labeled DNA probes that hybridize to either side of the MALT1 breakpoint (prototype version of the Vysis, Inc. MALT1 probe). As the signals were observed with filters through which the SpectrumOranget fluorophore appears red and the SpectrumGreent fluorophore appears green, the colors will be referred to as red (R) and green (G) in this article. Yellow fusion signals will be referred to as F. The API2, IGH, MALT1, and BCL2 probes span API2, IGH, MALT1, and BCL2, respectively. Thus, a D-FISH (dual fusion) pattern (1R1G2F) is produced using the appropriate probe set if IGH-BCL2, API2-MALT1, or IGH-MALT1 fusion is present. The API2-MALT1, CEN3/CEN7, and CEN12/CEN18 probe sets were applied in all cases. The IGH-BCL2 and IGH-MALT1 probe sets and the MALT1 breakapart probe were applied in selected cases.
Statistical analysis
FISH specimens were studied in random order in an independent and blinded manner by two microscopists (RRE and SFP). Each microscopist scored 100 consecutive qualifying interphase nuclei from different areas of the same slide. The normal ranges were calculated in previous published 10 and unpublished studies using lymph nodes and tonsils from patients without a malignant hematological disorder. The upper bound of the normal range was determined using a one-sided 95% confidence interval for observing the maximum number of nuclei for each false-positive signal pattern seen in 200 scoreable nuclei using the binomial distribution.
Results
FISH analysis
The FISH results are summarized in Table 1 . API2-MALT1 fusion was identified in seven of 28 primary pulmonary MALT lymphomas (25%). The mean percent and standard deviation of nuclei per case with an abnormal FISH pattern was 62.6714.2 with a range of 40-85. FISH patterns included patterns also represent API2-MALT1 fusion, with the 2R1G1F pattern resulting from a breakpoint within the API2 hybridization site and a breakpoint outside the MALT1 hybridization site, and the 1R2G1F pattern resulting from a breakpoint outside the API2 hybridization site and a breakpoint within the MALT1 hybridization site. Alternatively, it is possible that loss of DNA around the break and fusion point has occurred in either API2 or MALT1.
All seven API2-MALT1 fusion-positive MALT lymphomas had a normal FISH pattern using centromeric probes to chromosomes 7, 12, and 18. Five of seven API2-MALT1 fusion-positive MALT lymphomas also had a normal FISH pattern using a centromeric probe to chromosome 3, and the remaining two cases showed trisomy 3 in a subset of cells (mean 16% of cells).
In three cases (11%), an extra MALT1 signal was seen using the API2-MALT1 probe (Figure 1g ), but a normal signal pattern (Figure 1k ), indicating that this was indeed IGH-MALT1 fusion. A MALT1 breakapart probe also showed splitting of the probe in each case (mean 74%, range 61-85% of cells per case) (Figure 1l ), consistent with IGH-MALT1 fusion. In addition, both trisomy 3 and trisomy 12 were seen in two of the three cases in a majority of the cells. The remaining case had a normal FISH pattern using centromeric probes to chromosomes 3, 7, 12, and 18. In all, 11 cases (39%) that lacked both API2-MALT1 and IGH-MALT1 fusion had aneuploidy involving one or more of the chromosomes tested (Figures 1d-f ). Trisomy 3 (n ¼ 10) and trisomy 18 (n ¼ 7) were most frequently seen, and trisomy 12 (n ¼ 3) was also identified. None of the cases showed trisomy 7. The most common combination was trisomy 3 and trisomy 18. As expected, all cases with trisomy 18 had an extra CEN18 signal as well as an extra MALT1 signal using the API2-MALT1 probe. Finally, seven cases (25%) lacked cytogenetic abnormalities using this panel of FISH probes.
Immunohistochemistry
Bcl-10 expression was tested because ectopic nuclear localization of bcl-10 has been associated with t(11;18)(q21;q21). 6, 19, 20 In all, 11 of 27 cases (41%) showed ectopic nuclear localization of bcl-10 ( Table 1) . By cytogenetic category, ectopic nuclear localization of bcl-10 was seen in six of seven of cases (86%) with API2-MALT1 fusion, one of three cases (33%) with IGH-MALT1 fusion, two of 10 cases (20%) with aneuploidy alone, and two of seven cases (29%) without a detectable cytogenetic abnormality.
Discussion
To date, three recurrent structural chromosomal abnormalities have been described in MALT lymphoma. The first, t(11;18)(q21;q21), is thought to be the most common structural abnormality in MALT lymphoma, being present in 20-50% of cases. [1] [2] [3] [4] [5] [6] [7] [8] [9] It has previously been demonstrated in 38-55% of pulmonary MALT lymphomas 10, 12, 19 and was identified in 25% of primary pulmonary MALT lymphomas in the present study. This translocation results in the production of a fusion protein composed of the apoptosis inhibitor API2 on chromosome 11q21 and the paracaspase MALT1 on chromosome 18q21. t (11;18) has been shown to be prognostically and therapeutically significant in gastric MALT lymphomas, being associated with tumors that extend deeply into the gastric wall and/or disseminate beyond the stomach, 6 and also being associated with gastric MALT lymphomas that are Helicobacter pylorinegative 21 or fail to respond to H. pylori eradication therapy. 22, 23 The second translocation, t(1;14)(p22;q32), is thought to be uncommon in MALT lymphomas, although its incidence is presently unknown. It results in juxtaposition of BCL10 at 1p22 with the IGH promoter region at 14q32. A signal transduction pathway in which bcl-10 and MALT1 bind together to activate the IkB kinase complex, resulting in increased translocation into the nucleus and hence activation of NF-kappa B, has recently been described. 24 It has been postulated that both the t(1;14) and the t(11;18) can upregulate this pathway, the former due to increased bcl-10 expression binding to normal MALT1 and the latter due to expression of the API2-MALT1 fusion protein, which can self-oligomerize and activate NF-kappa B independent of bcl-10. 24, 25 Therefore, this pathway may represent the unifying feature between these two seemingly unrelated cytogenetic abnormalities in MALT lymphoma.
A third structural abnormality, t(14;18)(q32;q21), which juxtaposes the IGH promoter region at 14q32 with MALT1 at 18q21, was recently identified. 13, 14 Molecular cloning of the translocation breakpoints performed by Sanchez-Izquierdo et al 14 using a long-distance inverse polymerase chain reaction technique on two cases demonstrated that the MALT1 breakpoints lie immediately 5 0 to the first exons or are within the 5 0 noncoding regions. This translocation is thus analogous to other translocations involving IGH in that the coding regions of the partner gene remain intact, and it may represent a third independent chromosomal structural abnormality that potentiates MALT lymphoma progression by upregulating the NF-kappa B signal transduction pathway. Streubel et al 13 identified t(14;18)(q32;q21) by two-color FISH analysis in 12 of 66 MALT lymphomas (18%) arising in sites such as liver (four of four), skin (three of 11), ocular adnexa (three of eight), and salivary gland (two of 11), but not in MALT lymphomas arising in other sites such as stomach, intestine, lung (n ¼ 7), thyroid, or breast. In our laboratory, IGH-MALT1 fusion was detected by two-color FISH analysis in three of 28 primary pulmonary MALT lymphomas (11%). As this translocation is relatively uncommon, we postulate that the discrepancy regarding its presence in pulmonary MALT lymphomas simply reflects the difference in sample size (n ¼ 7 versus n ¼ 28), although the possibility of geographic variability cannot be excluded. Also, it is not clear whether the pulmonary MALT lymphomas in the Streubel et al study represented primary or recurrent disease. In a previous study of cytogenetic abnormalities of MALT lymphomas by FISH performed in our laboratory, 10 no abnormal FISH signal patterns that would have led us to suspect the presence of IGH-MALT1 fusion were identified in 37 specimens from diverse sites such as lung, parotid, orbit, stomach, thyroid, colon, small bowel, lacrimal gland, kidney, paravertebral region, and skin of scalp, suggesting that this translocation is indeed relatively uncommon. Similar to the findings of Streubel et al, in the present study API2-MALT1 and IGH-MALT1 fusions were mutually exclusive events.
The present study also provides additional support for the observation that API2-MALT1 fusion and aneuploidy are usually mutually exclusive events in MALT lymphoma. Similar to our previous study, 10 all API2-MALT1 fusion-positive MALT lymphomas lacked trisomy 7, 12, or 18, and all but two lacked trisomy 3, with the two exceptions showing trisomy 3 in only a subset of cells. Four MALT lymphomas have been previously described in which the major clone contained t(11;18)/API2-MALT1 fusion while a second, minor clone or subclone contained trisomy 3. 10, 26, 27 In contrast, two of the three IGH-MALT1 fusion-positive MALT lymphomas in our study showed aneuploidy (both trisomy 3 and trisomy 12) in the majority of cells. An association between IGH-MALT1 fusion and aneuploidy was also demonstrated by Streubel et al, who used centromeric probes for chromosomes 3 and 18 and found trisomy 37 trisomy 18 by FISH in four of 12 (33%) IGH-MALT1-positive MALT lymphomas. 13 Furthermore, 39% of our API2-MALT1 fusion-negative and IGH-MALT1 fusion-negative cases showed aneuploidy, usually involving chromosomes 3 and 18. This is similar to our previous study that showed aneuploidy (most commonly trisomy 3 and/or 18) in 41% of API2-MALT1 fusion-negative (and apparently IGH-MALT1 fusion-negative) MALT lymphomas. 10 Although aneuploidy has been suggested to be associated with recurrent disease in MALT lymphoma, 10 its pathogenetic significance is presently unknown. One could speculate that aneuploidy may be associated with other as yet unidentified structural chromosomal abnormalities such as t (1;14) , which by karyotypic studies has almost always been associated with aneuploidy. [28] [29] [30] [31] Additional studies will be necessary to investigate the pathogenetic and clinical significance of IGH-MALT1 fusion and aneuploidy in MALT lymphoma.
In contrast to cytoplasmic expression in normal B-cells, bcl-10 is expressed in the nucleus in MALT lymphomas harboring t(1;14) as well as in a subset of MALT lymphomas that lack this translocation. 32 Several studies have demonstrated an association between t(11;18) and ectopic nuclear bcl-10 expression, with nuclear bcl-10 expression being seen in 81-100% of t(11;18)-positive cases. 6, 19, 20 However, each study also identified a smaller group of t(11;18)-negative cases that also showed nuclear bcl-10 expression (16-30%). Our study showed similar findings, with nuclear bcl-10 expression being seen in 86% of API2-MALT1 fusion-positive cases and 25% of API2-MALT1 fusion-negative cases (one IGH-MALT1 fusion-positive case, two cases showing aneuploidy only, and two cases without apparent cytogenetic abnormality). This supports the concept that there is an association between API2-MALT1 fusion and nuclear bcl-10 expression, but suggests that nuclear bcl-10 expression may also be associated with a variety of cytogenetic abnormalities, albeit at a lower frequency.
The discovery of t(14;18)(q32;q21) involving IGH and MALT1 is also of diagnostic importance for routine clinical cases. Follicular lymphoma, which is usually associated with IGH-BCL2, and MALT lymphoma, which may be associated with IGH-MALT1, may be difficult to distinguish from one another by standard morphologic and immunophenotypic techniques, and cytogenetic analysis is sometimes employed. However, due to MALT1's close proximity to BCL2 on chromosome 18 at band q21, IGH-MALT1 is indistinguishable from IGH-BCL2 by standard cytogenetics. For this reason, both MALT lymphoma and follicular lymphoma must be considered in the differential diagnosis when t(14;18)(q32;q21) is identified by routine karyotyping. In at least one case in the literature, a tumor that appeared to have the morphologic and phenotypic features of a MALT lymphoma was diagnosed as follicular lymphoma, at least in part based on the presence of t(14;18)(q32;q21). 33 In order to differentiate IGH-MALT1 from IGH-BCL2, additional techniques such as FISH or PCR must be utilized.
